Catalyst Brief

← Calendar

Readoutin 135d

Pfizer — PG4 Multivalent Vaccine

Phase 3 primary completion: A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults.

Date
Apr 2027
Type
Readout
Indication
Pneumococcal Disease

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Pfizer

  1. Feb2027
    Readoutin 76d
    Pfizer — PF-06821497
    Phase 3 primary completion: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1)..
  2. Jan2027